MRP ₹11127
(Inclusive of all Taxes)
₹1669.0 Cashback (15%)
Provide Delivery Location
About Dashori 70 Tablet
Dashori 70 Tablet is an anti-cancer medicine used in the treatment of Leukemia. Leukemia, also known as blood cancer, is a cancer of blood cells or blood-forming tissues. It causes excessive production of immature white blood cells by the bone marrow and reduces the body’s ability to fight infections. There are different types of blood cancers. Dashori 70 Tablet is used in the treatment of chronic myelogenous leukemia (CML) in patients with chronic, accelerated, or blast phase Ph+ (Philadelphia chromosome-positive) who are resistant or intolerant to prior therapy, in patients with newly diagnosed chronic Ph+ chronic myelogenous leukemia (CML). This medicine is also used in the treatment of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL).
Dashori 70 Tablet contains Dasatinib, which belongs to the class of kinase inhibitors. It works by inhibiting the action of abnormal proteins that cause the multiplication of cancerous cells. This helps stop the abnormal growth of cancer cells and thus reduce the further spread to other parts of the body.
Dashori 70 Tablet may cause certain side effects, such as skin rash, fatigue, headache, musculoskeletal pain, decreased platelet count, nausea, vomiting, diarrhea, abdominal pain, dizziness, GI bleeding, muscle inflammation, myalgia, and difficulty breathing. These side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor. Dashori 70 Tablet should be taken as advised by your doctor. Do not take more than the recommended dose of medicine. Your doctor will decide the dose of Dashori 70 Tablet based on the severity of your condition.
Dashori 70 Tablet should be avoided if you are allergic to it or any other components present in it. Before taking Dashori 70 Tablet , caution should be exercised if you have/had liver/kidney disease, gastrointestinal disorders, cardiac problems, and myelosuppression as may cause serious side effects or worsen such conditions. This medicine is known to cause embryo-fetal toxicity. Hence, inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment with Dashori 70 Tablet . Breastfeeding should be discontinued in nursing mothers during the treatment.
Uses of Dashori 70 Tablet
Dashori 70 Tablet is used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. The detailed uses of Dashori 70 Tablet are as follows:

Have a query?
Directions for Use
Medicinal Benefits
Dashori 70 Tablet contains Dasatinib, which belongs to the class of kinase inhibitors. It works by inhibiting the action of abnormal proteins (BCR-ABL tyrosine kinase) that cause the multiplication of cancerous cells. This helps stop the abnormal growth of cancer cells and thus reduce the further spread to other parts of the body. Dashori 70 Tablet is used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia.
How Dashori 70 Tablet Works
Storage
What if I have taken an overdose of Dashori 70 Tablet
Drug Warnings
Dashori 70 Tablet should be avoided if you are allergic to it or any other components present in it. Let your doctor know about your complete medical history, including current medication, to rule out any side effects/interactions. Before taking, inform your doctor if you have liver/kidney disease, diabetes, cardiac problems, increased blood pressure, or gastrointestinal disorders, as the use of Dashori 70 Tablet in these patients may cause serious side effects. Dashori 70 Tablet may cause myelosuppression, fluid retention, gastrointestinal haemorrhage, QT prolongation, congestive heart failure, Left ventricular dysfunction and Myocardial infarction. This medicine is known to cause embryo-fetal toxicity. Hence, inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment. Breastfeeding should be discontinued in nursing mothers during the treatment. Dashori 70 Tablet is given in children above one year of age only if prescribed by the doctor. Avoid alcohol consumption and smoking, as it can lead to serious adverse effects.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
RXShilpa Medicare Ltd
₹80
(₹1.2 per unit)
RXZydus Healthcare Ltd
₹4522.5
(₹61.81 per unit)
RXMylan Pharmaceuticals Pvt Ltd
₹4589
(₹62.72 per unit)
Alcohol
Unsafe
Avoid alcohol consumption while on treatment with Dashori 70 Tablet to prevent serious adverse effects.
Pregnancy
Unsafe
When given to a pregnant woman, Dashori 70 Tablet may cause fetal harm. There have been no sufficient and well-controlled investigations of Dashori 70 Tablet in pregnant women. Women of reproductive potential should avoid becoming pregnant while undergoing treatment with this medicine.
Breast Feeding
Unsafe
It is not known if Dashori 70 Tablet passes into your breast milk. Inform your doctor if you are breastfeeding. You should not breastfeed while taking this medicine and for 2 weeks of the treatment with Dashori 70 Tablet . Your doctor may prescribe an alternative based on the symptoms and health condition.
Driving
Unsafe
Dashori 70 Tablet may cause dizziness and may make you feel drowsy. Hence, avoid driving or operating machines after taking Dashori 70 Tablet or until you become alert.
Liver
Caution
Use Dashori 70 Tablet with caution if you have liver disease. Your doctor may monitor your liver function while taking this medicine. No dose adjustments are necessary in patients with liver impairment.
Kidney
Caution
There are presently no clinical investigations with Dashori 70 Tablet in patients with compromised renal function. If you have kidney problems, inform your doctor before taking this medicine.
Children
Consult your doctor
Dashori 70 Tablet is safe for use in children above one year of age if prescribed by the doctor.
Heart
Dashori 70 Tablet may increase the risk of heart problems. Therefore, please inform your doctor if you have any heart-related problems before using Dashori 70 Tablet .
Geriatrics
Consult your doctor
Please consult a doctor before administering Dashori 70 Tablet to geriatric patients. Your doctor will prescribe Dashori 70 Tablet if the benefits outweigh the risks.
Dashori 70 Tablet is used to treat Philadelphia chromosome-positive chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
Dashori 70 Tablet contains Dasatinib, which works by inhibiting the action of abnormal proteins that cause the multiplication of cancerous cells.
Dashori 70 Tablet is known to cause embryo-fetal toxicity; hence, it is contraindicated for use in pregnancy. A woman needs to have a negative pregnancy test before starting treatment with this medicine. It is better to use effective birth control methods to prevent pregnancy while taking this medicine or at least six months after completion of the treatment.
Take antacids such as aluminium hydroxide/magnesium hydroxide, calcium carbonate, calcium carbonate, and magnesium 2 hours before or after taking Dashori 70 Tablet as antacids may alter the absorption of this medicine.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information